Sigma Pharmaceuticals Limited (“Sigma”) announced today that it has agreed to acquire Orphan Holdings Pty Ltd (“Orphan Australia”) from its existing shareholders, which include AMP Capital Investors and Orphan Australia’s founder and Executive Chairman, Mr Alastair Young for $130 million in cash.
